Communicating risks during pregnancy: a workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs.
暂无分享，去创建一个
[1] P. Lundborg,et al. Classification of drugs for teratogenic risk , 2004, European Journal of Clinical Pharmacology.
[2] J M Friedman,et al. Teratogenicity of Recently Introduced Medications in Human Pregnancy , 2002, Obstetrics and gynecology.
[3] M. Cheok,et al. Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks? , 2002, American journal of obstetrics and gynecology.
[4] D. Kennedy,et al. Risk Management Strategies in the Physicians’ Desk Reference Product Labels for Pregnancy Category X Drugs , 2002, Drug safety.
[5] P. Doering,et al. FDA Labeling System for Drugs in Pregnancy , 2001, The Annals of pharmacotherapy.
[6] N. Magrini,et al. Drug use during pregnancy , 2001, The Lancet.
[7] A. Addis,et al. Risk Classification Systems for Drug Use During Pregnancy , 2000, Drug safety.
[8] J. Friedman. Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugs. , 1993, Teratology.
[9] A. Scialli. A Clinical Guide to Reproductive and Developmental Toxicology , 1991 .
[10] T H Shepard,et al. Potential human teratogenicity of frequently prescribed drugs , 1990 .